AstraZenecaA brief overview
Pre-Pharmacy Society MeetingUniversity of DelawareRocco R. Duran R.Ph.Senior QA Executive – Global Quality Operations
2
Everyone cares about healthYoung or old. Rich or poor. Around the world. It’s one thingthat we all have in common
AstraZeneca is here to makea difference to people’s health
3
Doctors and patients
70 years of innovative medicines Touching the lives of many people
People who pay for healthcare
Our shareholders
The wider community
Our employees
4
Our focus is on six areas of medicine
Cancer
Cardiovascular disease
Infection
Gastrointestinal disease
Neurological disorders
Respiratory & inflammatory conditions
Top 8%Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success. We are positioned in the top 8% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes.
We employ over 61,000 people 47% in Europe, 30% in the Americas, 23% in Asia, Africa and Australasia
We invest over $4 billion in R&D each year and have over 15,500 people in our R&D organisation
In 2010, our worldwide sales totalled $33.3 billion).
|Pre-Pharmacy Society Meeting – November 10, 20116
Thank you for your time and interest
For more information about AstraZeneca and activities worldwide, visit astrazeneca.com